View : 635 Download: 0

Velcade (R), thalidomide, dexamethasone (VTD) induction therapy followed by melphalan, prednisone, thalidomide (MPT) maintenance as a first line treatment for the patients (pts) with multiple myeloma (MM) who are non-transplant candidates: Early analysis from the Korean multiple myeloma working party

Title
Velcade (R), thalidomide, dexamethasone (VTD) induction therapy followed by melphalan, prednisone, thalidomide (MPT) maintenance as a first line treatment for the patients (pts) with multiple myeloma (MM) who are non-transplant candidates: Early analysis from the Korean multiple myeloma working party
Authors
Eom, HyeonSeokKim, Yeo-KyeoungChung, JooseopKim, KihyunKim, HyoJeongJin, JongYulDo, Young-RokOh, SukjoongKim, HoYoungSuh, CheolwonSeong, Chu-MyongKim, Chul SooLee, Dong SoonLee, Jae Hoon
Ewha Authors
성주명
SCOPUS Author ID
성주명scopus
Issue Date
2007
Journal Title
BLOOD
ISSN
0006-4971JCR Link
Citation
BLOOD vol. 110, no. 11, pp. 282B - 282B
Publisher
AMER SOC HEMATOLOGY
Indexed
SCI; SCIE; SCOPUS WOS
Document Type
Meeting Abstract
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE